• Consensus Rating: Buy
  • Consensus Price Target: $24.56
  • Forecasted Upside: 12.35 %
  • Number of Analysts: 10
  • Breakdown:
  • 1 Sell Ratings
  • 1 Hold Ratings
  • 8 Buy Ratings
  • 0 Strong Buy Ratings
$21.86
▲ +1.31 (6.37%)

This chart shows the closing price for IMAX by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New IMAX Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for IMAX and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for IMAX

Analyst Price Target is $24.56
▲ +12.35% Upside Potential
This price target is based on 10 analysts offering 12 month price targets for IMAX in the last 3 months. The average price target is $24.56, with a high forecast of $30.00 and a low forecast of $18.60. The average price target represents a 12.35% upside from the last price of $21.86.

This chart shows the closing price for IMAX for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 10 contributing investment analysts is to buy stock in IMAX. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 1 sell ratings
4/30/2020
  • 0 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 1 sell ratings
7/29/2020
  • 0 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 1 sell ratings
10/27/2020
  • 0 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 1 sell ratings
1/25/2021
  • 0 strong buy ratings
  • 7 buy ratings
  • 0 hold ratings
  • 1 sell ratings
4/25/2021
  • 0 strong buy ratings
  • 7 buy ratings
  • 0 hold ratings
  • 1 sell ratings
7/24/2021
  • 0 strong buy ratings
  • 7 buy ratings
  • 1 hold ratings
  • 1 sell ratings
9/22/2021
  • 0 strong buy ratings
  • 8 buy ratings
  • 1 hold ratings
  • 1 sell ratings
10/22/2021

Latest Recommendations

  • 0 strong buy ratings
  • 8 buy ratings
  • 1 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
10/22/2021Wells Fargo & CompanyInitiated CoverageOverweight$27.00High
10/11/2021B. RileyBoost Price TargetOutperform ➝ Buy$28.00 ➝ $30.00High
8/11/2021WedbushReiterated RatingBuy$26.00Medium
7/29/2021Barrington ResearchLower Price TargetOutperform$27.00 ➝ $22.00High
7/28/2021Barrington ResearchReiterated RatingBuy$27.00Medium
7/28/2021JPMorgan Chase & Co.Lower Price TargetNeutral$24.00 ➝ $20.00High
7/26/2021Colliers SecuritiesReiterated RatingBuy$22.00High
6/2/2021The Goldman Sachs GroupDowngradeNeutral ➝ Sell$19.60 ➝ $18.60High
5/24/2021BenchmarkBoost Price TargetBuy$24.00 ➝ $25.00Medium
4/30/2021MacquarieBoost Price TargetOutperform$25.00 ➝ $30.00High
4/29/2021WedbushUpgradeNeutral ➝ Outperform$22.00 ➝ $26.00N/A
4/23/2021WedbushUpgradeNeutral ➝ Outperform$22.00 ➝ $26.00Low
3/16/2021B. RileyReiterated RatingBuy$28.00High
3/9/2021Barrington ResearchBoost Price Target$25.00 ➝ $27.00Low
3/5/2021MacquarieBoost Price TargetPositive ➝ Outperform$24.00 ➝ $25.00High
3/5/2021BenchmarkBoost Price TargetHold ➝ Buy$22.00 ➝ $24.00High
3/1/2021WedbushBoost Price TargetNeutral$14.00 ➝ $22.00Low
2/1/2021MKM PartnersBoost Price TargetBuy$18.00 ➝ $25.00Low
1/26/2021B. RileyBoost Price TargetUnderperform$26.00 ➝ $28.00High
1/25/2021The Goldman Sachs GroupDowngradeBuy ➝ Neutral$15.60 ➝ $17.90High
12/29/2020B. RileyBoost Price TargetPositive ➝ Buy$18.00 ➝ $26.00N/A
12/21/2020B. RileyReiterated RatingBuy$18.00Low
10/12/2020B. RileyLower Price Target$21.00 ➝ $18.00High
9/4/2020B. RileyBoost Price Target$18.00 ➝ $21.00Low
9/2/2020Barrington ResearchBoost Price TargetOutperform$15.00 ➝ $18.00Medium
9/1/2020The Goldman Sachs GroupBoost Price Target$14.00 ➝ $16.00Low
7/29/2020Barrington ResearchReiterated RatingBuy$15.00High
7/29/2020Canaccord GenuityReiterated RatingIn-Line ➝ Buy$16.00 ➝ $14.50High
7/29/2020B. RileyReiterated RatingBuy$18.00High
7/24/2020WedbushInitiated CoverageHold$14.00Low
7/20/2020Barrington ResearchReiterated RatingOutperformHigh
7/16/2020B. RileyReiterated RatingBuy$18.00High
7/15/2020The Goldman Sachs GroupInitiated CoverageBuy$14.00High
7/13/2020MKM PartnersLower Price TargetBuy$20.00 ➝ $18.00High
5/1/2020Canaccord GenuityReiterated RatingBuy$16.00High
5/1/2020B. RileyReiterated RatingBuy$19.00Low
4/30/2020Barrington ResearchReiterated RatingBuy$15.00Low
4/28/2020BenchmarkUpgradeHold ➝ Buy$14.00High
4/24/2020WedbushDowngradeOutperform ➝ Neutral$25.00 ➝ $12.00Low
4/15/2020MKM PartnersLower Price TargetBuy$24.00 ➝ $20.00Medium
4/2/2020B. RileyReiterated RatingBuy$19.00High
3/24/2020Barrington ResearchReiterated RatingOutperform$20.00 ➝ $15.00High
3/18/2020B. RileyLower Price TargetBuy$26.00 ➝ $19.00High
3/17/2020BenchmarkDowngradeBuy ➝ HoldHigh
3/17/2020JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$22.00 ➝ $15.00High
2/24/2020Barrington ResearchLower Price TargetOutperform$24.00 ➝ $20.00High
2/20/2020WedbushBoost Price TargetOutperform$22.00 ➝ $25.00High
2/20/2020Canaccord GenuityUpgradeBuy$23.00High
2/12/2020B. RileyReiterated RatingBuy$30.00 ➝ $26.00Low
2/4/2020MKM PartnersLower Price TargetBuy$24.00High
2/3/2020WedbushReiterated RatingOutperform$28.00 ➝ $22.00Low
1/29/2020BenchmarkLower Price TargetBuy$28.00 ➝ $20.00High
12/5/2019B. RileyReiterated RatingBuy$30.00Low
11/19/2019MKM PartnersReiterated RatingBuy$28.00Low
11/1/2019WedbushReiterated RatingHold ➝ Buy$28.00Low
11/1/2019Canaccord GenuityUpgradeHold ➝ Buy$25.00Medium
10/21/2019WedbushSet Price TargetBuy$28.00Low
10/15/2019The Goldman Sachs GroupSet Price TargetHold$23.00Low
9/10/2019B. RileySet Price TargetBuy$34.00High
7/31/2019WedbushReiterated RatingOutperform$28.00Low
7/16/2019WedbushReiterated RatingBuy$28.00Low
7/12/2019B. RileySet Price TargetBuy$34.00Low
5/20/2019B. RileySet Price TargetBuy$34.00Low
4/26/2019B. RileySet Price TargetBuy$34.00Low
4/22/2019WedbushSet Price TargetBuy$28.00Medium
4/12/2019MKM PartnersBoost Price TargetBuy$28.00Low
4/8/2019B. RileySet Price TargetBuy$34.00Low
3/6/2019Barrington ResearchReiterated RatingBuy$27.00Low
2/25/2019Canaccord GenuityDowngradeBuy ➝ Hold$23.00High
2/22/2019WedbushReiterated RatingOutperform$28.00Medium
1/30/2019WedbushReiterated RatingOutperformLow
1/2/2019B. RileySet Price TargetBuy$34.00Low
12/24/2018B. RileySet Price TargetBuy IMAX$34.00High
12/7/2018B. RileySet Price TargetBuy$34.00Low
10/29/2018Barrington ResearchLower Price TargetOutperform$27.00Low
10/26/2018Canaccord GenuityLower Price TargetBuy ➝ Buy$26.00 ➝ $23.00High
10/15/2018WedbushSet Price TargetBuy$29.00Low
7/26/2018WedbushSet Price TargetBuy$32.00High
7/3/2018WedbushReiterated RatingBuy$32.00Low
5/2/2018B. RileyLower Price TargetBuy ➝ Buy$37.75 ➝ $34.00Medium
4/27/2018WedbushSet Price TargetBuy$32.00Low
4/27/2018BenchmarkUpgradeHold ➝ Buy$28.00Low
4/25/2018Canaccord GenuitySet Price TargetBuy$26.00Medium
4/9/2018WedbushSet Price TargetBuy$32.00Medium
3/20/2018Barrington ResearchReiterated RatingBuy$30.00Medium
2/28/2018Roth CapitalReiterated RatingBuy ➝ Neutral$25.00 ➝ $22.50High
2/28/2018B. RileyBoost Price TargetBuy ➝ Buy$35.00 ➝ $37.75High
2/20/2018JPMorgan Chase & Co.Initiated CoverageOverweight ➝ Overweight$27.00 ➝ $28.00Medium
2/20/2018WedbushSet Price TargetOutperform$30.00Medium
1/10/2018Piper Jaffray CompaniesDowngradeOverweight ➝ Neutral$28.00 ➝ $21.00Low
1/8/2018B. RileyReiterated RatingBuy$35.00High
1/8/2018WedbushSet Price TargetBuy$30.00High
12/11/2017B. RileyReiterated RatingBuy$35.00Medium
11/20/2017B. RileyReiterated RatingBuy$35.00N/A
10/30/2017Barrington ResearchUpgradeMarket Perform ➝ Outperform$32.00N/A
10/27/2017B. RileyReiterated RatingBuy$35.00N/A
10/27/2017WedbushReiterated RatingBuy$31.00N/A
10/27/2017JPMorgan Chase & Co.UpgradeNeutral ➝ OverweightN/A
10/23/2017Canaccord GenuitySet Price TargetBuy$32.00N/A
10/19/2017WedbushSet Price TargetBuy$29.00N/A
10/19/2017B. RileySet Price TargetBuy$35.00N/A
10/10/2017WedbushReiterated RatingBuy$29.00N/A
9/28/2017Credit Suisse GroupLower Price TargetNeutral$26.00 ➝ $25.00Low
9/17/2017Piper Jaffray CompaniesReiterated RatingBuy$28.00Low
8/18/2017Canaccord GenuitySet Price TargetBuy$33.00Low
8/3/2017JPMorgan Chase & Co.Reiterated RatingNeutral$27.00Low
8/1/2017B. RileyReiterated RatingBuy$35.00Medium
7/27/2017B. RileyReiterated RatingBuy$35.00High
7/27/2017WedbushReiterated RatingBuyHigh
7/21/2017Piper Jaffray CompaniesSet Price TargetBuy$35.00Low
7/20/2017WedbushReiterated RatingOutperform$35.00Low
7/12/2017Barrington ResearchDowngradeOutperform ➝ Market PerformHigh
7/10/2017B. RileyReiterated RatingBuy$43.50Low
7/7/2017MKM PartnersLower Price TargetBuy$40.00 ➝ $30.00Medium
7/5/2017B. RileyReiterated RatingBuy$43.50High
6/18/2017B. RileyReiterated RatingBuy$43.50Low
6/13/2017Piper Jaffray CompaniesReiterated RatingBuyMedium
6/13/2017Roth CapitalSet Price TargetBuy$33.00Medium
6/12/2017B. RileyReiterated RatingBuy$43.50High
6/8/2017Canaccord GenuitySet Price TargetBuy$33.00Low
6/7/2017BenchmarkDowngradeBuy ➝ HoldHigh
5/20/2017B. RileyReiterated RatingBuy$46.00Low
5/15/2017B. RileyReiterated RatingBuy$46.00High
5/12/2017WedbushReiterated RatingOutperform$39.00High
4/27/2017B. RileyReiterated RatingBuy$46.00Low
4/25/2017MKM PartnersReiterated RatingBuy$40.00Low
4/22/2017B. RileyReiterated RatingBuy$46.00Medium
4/21/2017WedbushLower Price TargetOutperform ➝ Outperform$41.50 ➝ $39.00Low
4/20/2017Roth CapitalSet Price TargetBuy$37.00Low
4/17/2017B. RileyReiterated RatingBuy$46.00High
4/10/2017Canaccord GenuityReiterated RatingBuy$39.00Low
3/2/2017B. RileyReiterated RatingBuy$46.00N/A
2/27/2017Canaccord GenuitySet Price TargetBuy$39.00N/A
2/26/2017Barrington ResearchReiterated RatingOutperform$40.00N/A
2/25/2017B. RileyReiterated RatingBuy$46.00N/A
2/24/2017WedbushReiterated RatingOutperform$41.50N/A
2/20/2017B. RileyReiterated RatingBuy$46.00N/A
2/18/2017Canaccord GenuitySet Price TargetBuy$39.00N/A
2/15/2017B. RileyReiterated RatingBuy$46.00N/A
2/14/2017WedbushReiterated RatingOutperform$41.50N/A
1/31/2017Credit Suisse GroupDowngradeOutperform ➝ Neutral$34.00N/A
1/18/2017MKM PartnersReiterated RatingBuy$40.00N/A
1/13/2017Canaccord GenuityReiterated RatingBuyN/A
1/8/2017B. RileyReiterated RatingBuy$46.00N/A
1/3/2017B. RileyReiterated RatingBuy$41.50 ➝ $46.00N/A
12/20/2016Canaccord GenuitySet Price TargetBuy$39.00N/A
12/20/2016Stifel NicolausReiterated RatingBuy$40.00N/A
12/9/2016B. RileyReiterated RatingBuy$41.50N/A
12/4/2016B. RileyReiterated RatingBuy$41.50N/A
11/29/2016B. RileyReiterated RatingBuy$42.50 ➝ $41.50N/A
11/16/2016B. RileyReiterated RatingBuy$42.50N/A
11/11/2016Credit Suisse GroupInitiated CoverageOutperform$42.00N/A
10/27/2016B. RileyReiterated RatingBuy$42.50N/A
10/23/2016WedbushSet Price TargetBuy$42.00N/A
(Data available from 10/22/2016 forward)

News Sentiment Rating

0.24 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 14 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/26/2021
  • 0 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/25/2021
  • 0 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/25/2021
  • 0 very positive mentions
  • 11 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/24/2021
  • 3 very positive mentions
  • 13 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
7/24/2021
  • 6 very positive mentions
  • 11 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
8/23/2021
  • 5 very positive mentions
  • 10 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
9/22/2021
  • 5 very positive mentions
  • 19 positive mentions
  • 5 negative mentions
  • 1 very negative mentions
10/22/2021

Current Sentiment

  • 5 very positive mentions
  • 19 positive mentions
  • 5 negative mentions
  • 1 very negative mentions

Recent Stories by Sentiment

IMAX logo
IMAX Corp. is an entertainment technology company, which engages in the business of motion picture technologies and presentations. It operates through following four business segments: IMAX Technology Network; IMAX Technology Sales and Maintenance; New Business Initiatives; and Film Distribution and Post-Production. The IMAX Technology Network segment represents box office results and which includes the reportable segment of IMAX DMR and contingent rent from the joint revenue sharing arrangements and IMAX systems segments. The IMAX Technology Sales and Maintenance segment includes the sale and installation of theater systems and maintenance services, primarily related to the IMAX Systems and Theater System Maintenance. The New Business Initiatives segment involves content licensing and distribution fees associated with the firm's original content investments, virtual reality initiatives, IMAX Home Entertainment, and other business initiatives that are in the development and/or start-up phase. The Film Distribution and Post-Production segment provides licenses film content and distributes large-format films, primarily for its institutional theater partners. The company was founded
Read More

Today's Range

Now: $21.86
Low: $20.56
High: $21.86

50 Day Range

MA: $17.08
Low: $13.67
High: $21.34

52 Week Range

Now: $21.86
Low: $10.76
High: $25.05

Volume

65,116 shs

Average Volume

838,982 shs

Market Capitalization

$1.30 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.77

Frequently Asked Questions

What sell-side analysts currently cover shares of IMAX?

The following Wall Street analysts have issued research reports on IMAX in the last twelve months: B. Riley, Barrington Research, Benchmark Co., Colliers Securities, JPMorgan Chase & Co., Macquarie, MKM Partners, The Goldman Sachs Group, Inc., TheStreet, Wedbush, Wells Fargo & Company, and Zacks Investment Research.
View the latest analyst ratings for IMAX.

What is the current price target for IMAX?

10 Wall Street analysts have set twelve-month price targets for IMAX in the last year. Their average twelve-month price target is $24.56, suggesting a possible upside of 17.1%. Macquarie has the highest price target set, predicting IMAX will reach $30.00 in the next twelve months. The Goldman Sachs Group, Inc. has the lowest price target set, forecasting a price of $18.60 for IMAX in the next year.
View the latest price targets for IMAX.

What is the current consensus analyst rating for IMAX?

IMAX currently has 1 sell rating, 1 hold rating and 8 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe IMAX will outperform the market and that investors should add to their positions of IMAX.
View the latest ratings for IMAX.

What other companies compete with IMAX?

Other companies that are similar to IMAX include GoPro, Eastman Kodak, Ballantyne Strong, Moving iMage Technologies and ImageWorks.

How do I contact IMAX's investor relations team?

IMAX's physical mailing address is 2525 Speakman Drive, Mississauga A6, L5K 1B1. The company's listed phone number is (905) 403-6500 and its investor relations email address is [email protected] The official website for IMAX is www.imax.com.